On June 29, 2023, Heading Health Inc. closed the transaction. The company received $4,500,000 in the transaction co-led by new investors Gron Ventures and JAM Fund. The transaction included participation from new investors One Mind Accelerator, Thiel Capital, Mystic Ventures, Gaingels and Anti Fund Investment Fund, LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.165 CAD | -23.26% | -23.26% | +65.00% |
04-29 | Entheon Biomedical Corp. Reports Earnings Results for the First Quarter Ended February 29, 2024 | CI |
04-18 | Entheon Biomedical Corp. announced that it has received CAD 0.1475 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
+65.00% | 1.07M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ENBI Stock
- News Entheon Biomedical Corp.
- Heading Health Inc. announced that it has received $4.5 million in funding from a group of investors